Pilot Trial of K562/GM-CSF Whole-Cell Vaccination in MDS Patients

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell malignancies. Currently approved drugs are given with non-curative intent as the only known cure is allogeneic bone marrow transplantation, which relies on the donor’s immune system driving an allogeneic effe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Leuk Lymphoma
Päätekijät: Robinson, Tara M., Prince, Gabrielle T., Thoburn, Chris, Warlick, Erica, Ferguson, Anna, Kasamon, Yvette L., Borrello, Ivan M., Hess, Allan, Smith, B. Douglas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352988/
https://ncbi.nlm.nih.gov/pubmed/29616857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1443449
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia